Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Rallis India Ltd

| Q4 & FY26 Earnings Conference Call

NEUTRAL SENTIMENT

Report Source

⬤5th May 26

Summary : Rallis India delivered reasonable Q4FY26 results, driven by new products and efficiency, but faces external risks from weather and geopolitical events.

Management Perspective neutral : Management acknowledges challenging external factors like weather and geopolitical unrest, but emphasizes internal strengths such as improved efficiency, new product launches, and strategic focus on passing on cost increases. The tone is balanced, recognizing both headwinds and proactive measures.

Concall Report Analysis & Insights

Business Overview

  1. Rallis India reported Q4FY26 revenue of 456 crore, a 6% increase year-on-year.
  2. EBITDA improved by 96% to -1 crore from -19 crore in Q4FY25.
  3. Crop Care segment grew 5%, Domestic B2C grew 15%, and Seeds revenue increased 23%.
  4. Overall annual capacity utilization improved in FY26 compared to FY25.
  5. Launched new products ALSTOR, FIPLAM, and Spiro, along with two new seed products.

Future Growth Prospects

  1. The agrochemical sector is projected to grow 3-4% in FY27, with seeds at 5-10% CAGR.
  2. Company is expanding its customer base and product portfolio for business resilience.
  3. Digital initiatives like Saksham and Sampark Plus aim for targeted market expansion and sales conversion.
  4. Focusing on high-margin, sustainable, and farmer-centric offerings, including biologicals.
  5. The aquafeed business is an experimental segment with long-term growth potential.

Management Insights

  1. Q4FY26 performance was reasonable despite a short Rabi season and geopolitical unrest.
  2. We are continuously broadening our customer base and securing additional registrations.
  3. Disciplined in improving capital efficiency across fixed and working capital.
  4. We are one of the first to announce price increases to offset rising costs.
  5. We are being conservative on pre-placing stock to capitalize on higher realization opportunities.

Risk Factors

  1. Unfavorable climate and unseasonal rains damaged Rabi crops across 2.49 lakh hectares.
  2. IMD's 2026 monsoon forecast signals below-normal rains (92% LPA), dampening agri-economy.
  3. Erratic rainfall patterns risk 5-10% demand cuts for herbicides and insecticides.
  4. Geopolitical tensions and China supply disruptions cause rising costs and supply chain issues.
  5. Elevated raw material and logistics costs continue to pressure manufacturers' margins.

Good To Know

  1. India's FCO 2026 amendment will modernize bio stimulant fertilizer standards.
  2. The global crop protection market is estimated at USD 70-75 billion in 2026, growing at 5.0-5.5%.
  3. Launched Idea2Impact platform to establish an open innovation ecosystem for agri-innovations.
  4. The company has a healthy cash and liquid balance of 541 crore as of March 31, 2026.
  5. The B2B business recorded 14% growth, contributing 759 crore in revenue.

Key Drivers

  1. New product launches drive growth.
  2. Improved capacity utilization boosts output.
  3. Strategic focus on key crops.
  4. Digital initiatives enhance market reach.

Key Analyst Discussions

Competitive Environment

  1. The company prioritizes the domestic market for products like acephate due to supply challenges.
  2. Companies are generally indicating they must pass on cost increases to maintain viability.
  3. The market favors low-cost producers with export breadth and tight working capital discipline.
  4. Global recovery in the sector is uneven, with US demand supportive but Brazil weak.
  5. China-led pricing pressure remains a key concern in the global market.

Market Trends & Consumer Behavior

  1. Kharif demand is uncertain due to rainfall, commodity prices, and fertilizer availability.
  2. Farmers may down-trade to lower-priced seeds or crop protection products.
  3. Integrated firms with balanced portfolios (seeds + crop protection) fare best in volatility.
  4. Expanding irrigation coverage reduces monsoon dependence for key crops.
  5. Rural income diversification provides a structural buffer against rainfall deficits.

Financial Highlights

  1. Gross margin improvement was driven by CSM, SPH, B2B, and seed businesses.
  2. Inventory of older products (Clasto, Benzilla) was liquidated in Q4, impacting margins.
  3. Cost increases are in the range of 15-25%, which the company aims to pass on.
  4. Q4FY26 EBITDA improved significantly due to contract benefits in CSM and better B2B/seed performance.
  5. Overall revenue growth for FY26 was 9%, with Crop Care growing 8% and Seeds 15%.

Product Composition

  1. Q4 B2C growth was primarily driven by insecticides.
  2. Seed business focus is on cotton, maize, millet, and rice for operational efficiency.
  3. Management remains positive on metribuzin, pendimethalin, and hexaconazole.
  4. New products are being launched in segments where older products faced challenges.
  5. Soil & Plant Health category grew 27% with robust volume growth in micronutrients and biofertilizers.

Strategic Considerations

  1. Seed business is expected to achieve high double-digit growth, combining volume and price.
  2. The aquafeed business is currently an experimental, smaller-scale venture.
  3. Company prefers licensing technologies for GE seeds rather than extensive in-house R&D.
  4. Focus on selling more herbicides, soil and plant health products, and seeds.
  5. The company aims to continuously increase prices to compensate for rising commodity costs.